FDG-Avid But FAPI-Negative Intramucosal Carcinoma in a Colorectal Adenoma.

Clin Nucl MedMay 11, 2026 (epub)

Shinobu Adaniya, Masao Murakami, Toshimitsu Momose

✦ AI-curated · Sources linked

Case in brief

A man in his 70s presented for follow-up of hepatocellular carcinoma, undergoing both FDG PET/CT and 18F FAPI-74 PET/CT. The FDG PET revealed intense focal uptake in the sigmoid colon, while the FAPI PET showed no abnormal uptake. Endoscopic resection confirmed carcinoma in adenoma confined to the lamina propria, indicating a lack of desmoplastic reaction.

What made this case unusual

The case highlights a significant discrepancy between FDG and FAPI PET findings, with FDG showing uptake in an early-stage carcinoma while FAPI did not, suggesting limitations of FAPI in detecting intramucosal lesions.

Diagnostic / clinical pearl

Clinicians should be aware that FAPI PET may not be reliable for detecting early intramucosal carcinomas, particularly in adenoma-dominant lesions.

Why it matters

Understanding the limitations of FAPI PET in early colorectal lesions is crucial for accurate diagnosis and management, especially in cases where FDG PET indicates potential malignancy.

Source

Published in Clin Nucl Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.